ID   T3M-5
AC   CVCL_8064
SY   T3M5
DR   CLO; CLO_0050948
DR   BioSample; SAMN03472201
DR   Cosmic; 2009526
DR   DepMap; ACH-002042
DR   RCB; RCB1012
DR   Wikidata; Q54971539
RX   PubMed=6982994;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 22 hours, at 60th passage (PubMed=6982994).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gly108Val (c.323G>T); Zygosity=Unspecified (DepMap).
CC   Derived from sampling site: Thyroid gland.
ST   Source(s): RCB
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 12,13
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 13
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C46008; Thyroid gland squamous cell carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 15
RX   PubMed=6982994; DOI=10.1093/jnci/69.6.1235;
RA   Okabe T., Nomura H., Oshawa N.;
RT   "Establishment and characterization of a human colony-stimulating
RT   factor-producing cell line from a squamous cell carcinoma of the
RT   thyroid gland.";
RL   J. Natl. Cancer Inst. 69:1235-1243(1982).